The transcriptome of human epicardial, mediastinal and subcutaneous adipose tissues in men with coronary artery disease

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Guauque Olarte, Sandra ^a   Gaudreault, Nathalie ^a   Piché, Marie Ève ^a   Fournier, Dominique ^a   Mauriège, Pascale ^a,b   Mathieu, Patrick ^a   Bossé, Yohan ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME; ADENOSINE A1 RECEPTOR; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D ISOMERASE; PROSTAGLANDIN R2 D-ISOMERASE;

ADENOSINE A1 RECEPTOR GENE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOWN REGULATION; EPICARDIAL ADIPOSE TISSUE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MAPPING; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; MALE; MEDIASTINAL ADIPOSE TISSUE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROSTAGLANDIN D2 SYNTHASE GENE; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; UPREGULATION; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; MEDIASTINUM; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PERICARDIUM;

ADIPOSE TISSUE; AGED; CORONARY ARTERY DISEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; MEDIASTINUM; MIDDLE AGED; PERICARDIUM; RECEPTOR, ADENOSINE A1; SUBCUTANEOUS FAT;

EID: 79956129400     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019908     Document Type: Article

References (66)

1. Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, et al. (2008) Visceral obesity and the heart. Int J Biochem Cell Biol 40: 821-836.
2. Mathieu P, Lemieux I, Despres JP, (2010) Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 87: 407-416.
3. Despres JP, Lemieux I, (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
4. Sacks HS, Fain JN, (2007) Human epicardial adipose tissue: a review. Am Heart J 153: 907-917.
5. Rabkin SW, (2007) Epicardial fat: properties, function and relationship to obesity. Obes Rev 8: 253-261.
6. Iacobellis G, Willens HJ, (2009) Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 22: 1311-1319; quiz 1417-1318.
7. Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, et al. (2007) Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 71: 536-539.
8. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, et al. (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88: 5163-5168.
9. Iacobellis G, Willens HJ, Barbaro G, Sharma AM, (2008) Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 16: 887-892.
10. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, et al. (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108: 2460-2466.
11. Baker AR, Harte AL, Howell N, Pritlove DC, Ranasinghe AM, et al. (2009) Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab 94: 261-267.
12. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A, (2009) Cytokine network and T cell immunity in atherosclerosis. Semin Immunopathol 31: 23-33.
13. Ishii T, Asuwa N, Masuda S, Ishikawa Y, (1998) The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J Pathol 185: 4-9.
14. Iacobellis G, Corradi D, Sharma AM, (2005) Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2: 536-543.
15. Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, et al. (2009) Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 10: 549-555.
16. Kim MK, Tanaka K, Kim MJ, Matuso T, Endo T, et al. (2009) Comparison of epicardial, abdominal and regional fat compartments in response to weight loss. Nutr Metab Cardiovasc Dis 19: 760-766.
17. Pezeshkian M, Noori M, Najjarpour-Jabbari H, Abolfathi A, Darabi M, et al. (2009) Fatty acid composition of epicardial and subcutaneous human adipose tissue. Metab Syndr Relat Disord 7: 125-131.
18. Dutour A, Achard V, Sell H, Naour N, Collart F, et al. (2010) Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease. J Clin Endocrinol Metab 95: 963-967.
19. Funakoshi H, Chan TO, Good JC, Libonati JR, Piuhola J, et al. (2006) Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Circulation 114: 2240-2250.
20. Inoue T, Eguchi Y, Matsumoto T, Kijima Y, Kato Y, et al. (2008) Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis 201: 385-391.
21. Miwa Y, Oda H, Shiina Y, Shikata K, Tsushima M, et al. (2008) Association of serum lipocalin-type prostaglandin D synthase levels with subclinical atherosclerosis in untreated asymptomatic subjects. Hypertens Res 31: 1931-1939.
22. Djaberi R, Schuijf JD, van Werkhoven JM, Nucifora G, Jukema JW, et al. (2008) Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol 102: 1602-1607.
23. Vohl MC, Sladek R, Robitaille J, Gurd S, Marceau P, et al. (2004) A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res 12: 1217-1222.
24. Malavazos AE, Ermetici F, Coman C, Corsi MM, Morricone L, et al. (2007) Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int J Cardiol 121: 132-134.
25. Chen X, Jiao Z, Wang L, Sun Z, Wei Y, et al. (2010) Roles of human epicardial adipose tissue in coronary artery atherosclerosis. J Huazhong Univ Sci Technolog Med Sci 30: 589-593.
26. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, et al. (2009) Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30: 850-856.
27. Elzein E, Zablocki J, (2008) A1 adenosine receptor agonists and their potential therapeutic applications. Expert Opin Investig Drugs 17: 1901-1910.
28. Regan SE, Broad M, Byford AM, Lankford AR, Cerniway RJ, et al. (2003) A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity. Am J Physiol Heart Circ Physiol 284: H859-866.
29. Matherne GP, Linden J, Byford AM, Gauthier NS, Headrick JP, (1997) Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A 94: 6541-6546.
30. Urmaliya VB, Church JE, Coupar IM, Rose'Meyer RB, Pouton CW, et al. (2009) Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine. J Cardiovasc Pharmacol 53: 424-433.
31. Vikman HL, Ranta S, Kiviluoto T, Ohisalo JJ, (1991) Different metabolic regulation by adenosine in omental and subcutaneous adipose tissue. Acta Physiol Scand 142: 405-410.
32. Vikman HL, Ohisalo JJ, (1993) Regulation of adenylate cyclase in plasma membranes of human intraabdominal and abdominal subcutaneous adipocytes. Metabolism 42: 739-742.
33. Kurnik D, Muszkat M, Li C, Sofowora GG, Solus J, et al. (2006) Variations in the alpha2A-adrenergic receptor gene and their functional effects. Clin Pharmacol Ther 79: 173-185.
34. Brede M, Philipp M, Knaus A, Muthig V, Hein L, (2004) alpha2-adrenergic receptor subtypes- novel functions uncovered in gene-targeted mouse models. Biol Cell 96: 343-348.
35. Li JL, Canham RM, Vongpatanasin W, Leonard D, Auchus RJ, et al. (2006) Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks? Hypertension 47: 1140-1146.
36. Niederhoffer N, Hein L, Starke K, (2004) Modulation of the baroreceptor reflex by alpha 2A-adrenoceptors: a study in alpha 2A knockout mice. Br J Pharmacol 141: 851-859.
37. Rosengren AH, Jokubka R, Tojjar D, Granhall C, Hansson O, et al. (2010) Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327: 217-220.
38. Mauriege P, Galitzky J, Berlan M, Lafontan M, (1987) Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest 17: 156-165.
39. Mauriege P, Marette A, Atgie C, Bouchard C, Theriault G, et al. (1995) Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res 36: 672-684.
40. Vikman HL, Savola JM, Raasmaja A, Ohisalo JJ, (1996) Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes. Int J Obes Relat Metab Disord 20: 185-189.
41. Barakat H, Davis J, Lang D, Mustafa SJ, McConnaughey MM, (2006) Differences in the expression of the adenosine A1 receptor in adipose tissue of obese black and white women. J Clin Endocrinol Metab 91: 1882-1886.
42. Reynisdottir S, Dauzats M, Thorne A, Langin D, (1997) Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue. J Clin Endocrinol Metab 82: 4162-4166.
43. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF, (1991) Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metabolism 40: 990-996.
44. Fain JN, Sacks HS, Bahouth SW, Tichansky DS, Madan AK, et al. (2010) Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat. Metabolism 59: 1379-1386.
45. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, et al. (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47: 1384-1391.
46. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, et al. (1998) Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47: 98-103.
47. Iglesias MJ, Eiras S, Pineiro R, Lopez-Otero D, Gallego R, et al. (2006) [Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery]. Rev Esp Cardiol 59: 1252-1260.
48. Linder K, Arner P, Flores-Morales A, Tollet-Egnell P, Norstedt G, (2004) Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 45: 148-154.
49. Urs S, Smith C, Campbell B, Saxton AM, Taylor J, et al. (2004) Gene expression profiling in human preadipocytes and adipocytes by microarray analysis. J Nutr 134: 762-770.
50. Escary JL, Choy HA, Reue K, Wang XP, Castellani LW, et al. (1999) Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages. J Lipid Res 40: 397-404.
51. Hirawa N, Uehara Y, Yamakado M, Toya Y, Gomi T, et al. (2002) Lipocalin-type prostaglandin d synthase in essential hypertension. Hypertension 39: 449-454.
52. Cipollone F, Fazia M, Iezzi A, Ciabattoni G, Pini B, et al. (2004) Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 24: 1259-1265.
53. Ragolia L, Palaia T, Hall CE, Maesaka JK, Eguchi N, et al. (2005) Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J Biol Chem 280: 29946-29955.
54. Ragolia L, Palaia T, Paric E, Maesaka JK, (2003) Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells. J Biol Chem 278: 22175-22181.
55. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, et al. (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28: 1304-1310.
56. Canoy D, (2010) Coronary heart disease and body fat distribution. Curr Atheroscler Rep 12: 125-133.
57. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
58. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
59. Du P, Kibbe WA, Lin SM, (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
60. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
61. Eiras S, Teijeira-Fernandez E, Salgado-Somoza A, Couso E, Garcia-Caballero T, et al. (2010) Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression. Cytokine 51: 207-212.
62. Langheim S, Dreas L, Veschini L, Maisano F, Foglieni C, et al. (2010) Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am J Physiol Heart Circ Physiol 298: H746-753.
63. Gorzelniak K, Janke J, Engeli S, Sharma AM, (2001) Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm Metab Res 33: 625-627.
64. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129-2141.
65. Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, et al. (2006) Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 34: W645-650.
66. Chen J, Bardes EE, Aronow BJ, Jegga AG, (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-311.